Shares of Smith & Nephew (LON) experienced a significant rise on Thursday following the announcement that activist investor Cevian Capital has acquired a stake in the company.
Cevian Capital, based in Stockholm, disclosed that it now holds a 5% interest in Smith & Nephew, a renowned manufacturer of orthopaedic implants and prosthetics. This move comes at a time when Smith & Nephew’s stock has declined by more than 50% from its peak in 2020, partly influenced by changes in procurement practices in China and recent executive-level turnover. The company reported revenue of $1.39 billion for its fiscal first quarter, falling short of market estimates.
According to a statement from a Cevian partner reported by Reuters, the investor sees potential in enhancing Smith & Nephew’s operational performance to create long-term shareholder value.
Cevian Capital has a track record of investing in various businesses, including UBS, CRH (NYSE), and Pearson, highlighting its strategic approach across different sectors.
SN: A Bull or Bear Market Play?
Don’t miss out on potential opportunities! Stay informed with ProPicks – offering 6 model portfolios driven by AI stock picks that have demonstrated strong performance in 2024.
Related topics: